Recent findings suggested that cannabidiol, a terpenophenolic compound, may diminish the risk for NASH by downregulating NF-κB and NLRP3 inflammasome signaling pathways in macrophages in high-fat high cholesterol (HFC) diet-fed mice (66). Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.